Effective control and monitoring of foot-and-mouth disease (FMD) relies upon rapid and accurate disease confirmation. Currently, clinical samples are usually tested in reference laboratories using standardized assays recommended by The World Organisation for Animal Health (OIE). However, the requirements for prompt and serotype-specific diagnosis during FMD outbreaks, and the need to establish robust laboratory testing capacity in FMD-endemic countries have motivated the develop- Analytical sensitivity, diagnostic sensitivity and specificity of the pan-serotype-specific lyophilized assay were comparable to that of an OIE-recommended laboratory- rRT-PCR platforms in endemic settings for simple, highly sensitive and rapid detection and/or characterization of FMDV.
| INTRODUCTION
Early detection of foot-and-mouth disease virus (FMDV), a highly infectious picornavirus, is essential to minimize the impacts of footand-mouth disease (FMD) in susceptible populations. FMD is endemic in many countries throughout Africa, Asia and parts of South America, existing as seven distinct FMDV serotypes (A, O, C, Asia 1, Southern African Territories [SAT] 1, 2 and 3), which are distributed unevenly worldwide within seven geographically defined pools (Paton, Sumption, & Charleston, 2009) . Laboratory-based diagnostic tests play an essential role in FMD control and eradication by providing accurate confirmation of clinical signs. Real-time reverse-transcription polymerase chain reaction (rRT-PCR) has been widely adopted by FMD reference laboratories as a principal tool for FMDV detection, offering high analytical sensitivity and rapid sample throughput Shaw et al., 2007) . Pan-serotype-specific rRT-PCR assays, targeting conserved regions of the FMDV RNA genome (Callahan et al., 2002; Reid et al., 2002) , were used during the UK 2007 FMDV outbreak to test 99.1% of 3,246 diagnostic samples submitted to the UK National Reference Laboratory for FMD (The Pirbright Institute, UK) ).
Although laboratory-based tests provide rapid and accurate results, sample transportation to the laboratory can negatively affect the quality of the specimens (if shipped incorrectly) and delay/or even hinder the processes of immediate critical decision-making and disease control. Furthermore, many diagnostic procedures require sophisticated and expensive equipment, limiting their application in low-and middle-income countries (LMICs), which lack the infrastructure and financial resources for veterinary diagnostics and surveillance of endemic diseases such as FMD (Namatovu et al., 2013; Paton et al., 2009; Vosloo, Bastos, Sangare, Hargreaves, & Thomson, 2002) . The control of FMD has been recognized by the Food and Agricultural Organization of the United Nations (FAO) and The World Organisation for Animal Health (OIE) as a global priority (Sumption, Domenech, & Ferrari, 2012) . However, with effective control strategies requiring knowledge of FMD distribution and epidemiology, the deployment of simple point-of-care test (POCT) platforms for active FMDV detection, monitoring and characterization remains an ongoing research effort.
The compatibility of an OIE-recommended rRT-PCR assay with POCT platforms has already been demonstrated (Hearps, Zhang, & Alexandersen, 2002; Madi et al., 2012; Monwina, Clavijo, Li, Collignon, & Kitching, 2007; Paixão et al., 2008) . For instance, portable rRT-PCR has been deployed in field settings for accurate detection of FMDV in serum, epithelial suspensions and oesophageal-pharyngeal fluid (OP) fluid (Howson et al., 2015) . However, current assay formats and platforms are currently limited by low sample throughput, the requirement for RNA extraction (and thus methods and equipment to perform this) or are commercially unavailable. Furthermore, evaluation of POCT rRT-PCR platforms has only been performed using FMDV pan-serotype-specific assay formats. With methods of FMD control in endemic settings relying upon rapid and accurate identification of the particular FMDV serotype circulating in the field (e.g. targeted vaccination) (Sumption et al., 2012) , there have been efforts to design serotype-specific assays (tailored to the region) that target variable capsid-coding regions of the FMDV genome (Ahmed et al., 2012; Bachanek-Bankowska et al., 2016; Giridharan, Hemadri, Tosh, Sanyal, & Bandyopadhyay, 2005; Jamal & Belsham, 2015; Knowles et al., 2016; Reid et al., 2014 (Almassian, Cockrell, & Nelson, 2013) . The assessment was performed within laboratory and East African field settings, providing an approach that can type FMDV in situ using molecular methods.
| MATERIALS AND METHODS
Laboratory work was carried out at The Pirbright Institute (UK), the Foot-and-Mouth Disease Laboratory (Embakasi, Kenya) and Sokoine University of Agriculture (SUA) (Morogoro, Tanzania). Field work was carried out in FMD-endemic settings: Morogoro Region (Tanzania), Nakuru and Kericho County (Kenya) and Adama (Ethiopia) (Figure 1 ). These sites were selected on the basis of existing collaborations with investigators working on the epidemiology of FMD.
| Ethics
Clinical samples used in this study for laboratory evaluation were archival samples generated in previous in vivo studies approved by Samples comprised of serum (n = 11) and mouth swabs (n = 11) taken daily from two animals from the day of challenge and epithelium (n = 4) and OP fluid (n = 2) collected from the same animals post-mortem (carried out on the day of culling).
| Initial laboratory analysis of the lyophilized East Africa typing rRT-PCR reagents
Initial laboratory analysis of the East Africa-specific typing assay was performed on RNA extracted from 36 samples (serotypes O, A, SAT 1 and SAT 2) originating from East Africa (samples from Tanzania and Kenya included in Appendix S1). These samples were characterized by the WRLFMD using an antigen-detection ELISA (Ferris & Dawson, 1988 ) and sequencing of the VP1 region (Knowles et al., 2016) , as stated in the guidelines of the diagnostic manuals of the OIE (OIE, 2012). 
| Sample preparation for field evaluation
Loose epithelial tissue of ruptured vesicular lesions from either the mouth or feet was prepared using the SVANODIP â FMDV-Ag Extraction Kit and SVANODIP â FMDV-Ag LFD Kit (Boehringer Ingelheim) as previously described (Howson et al., 2015) . Epithelial samples from the feet (inter-digital space/coronary band) were briefly washed in nuclease free water (NFW) prior to processing to remove soil contaminants. The homogenate was left to settle for 1 min, and then, the supernatant was removed and diluted one in 10 in NFW prior to analysis.
Swabs (GenoTube Livestock, Thermo Fisher Scientific) were collected by swabbing the surface of ruptured lesions in the mouth or on the feet (inter-digital space/coronary band). The feet were cleaned in sterile water prior to swabbing in order to remove soil contaminants. Swabs were then agitated by hand in 1 ml NFW, which was used directly in analysis.
OP fluid was collected using a suitably sized probang cup following the guidelines within the diagnostic manuals of the OIE (2012) and diluted one in 10 in NFW prior to analysis.
Blood (10 ml) was collected from either the jugular or tail vein using Vacutainer â Plus Plastic Serum Tubes (BD, Plymouth, UK), or similar. Samples were then transported back to the local laboratory and centrifuged at 3,000 g for 10 min. Serum was removed and then diluted one in 10 in NFW prior to analysis.
| Real-time RT-PCR (rRT-PCR)
2.5.1 | Laboratory-based rRT-PCR An OIE-recommended pan-serotype-specific one-step rRT-PCR was used as the reference assay. Each sample was tested in duplicate, using primers and probes reported by Callahan et al. (2002) 
| rRT-PCR using the T-COR TM 8
The FMDV lyophilized pan-serotype-specific assay was performed in duplicate using FMDV 2.0 reagents with inhibition control (TC-9092-064, Tetracore Inc.). This assay contains proprietary primers and probes to target two areas within the highly conserved 3D 
| Statistical analysis
Cohen's Kappa statistic (j) and the proportion of observed agreement (A obs ) were used to measure the agreement between diagnostic tests. Statistical analyses were performed using R (R Core Team, 2014). (Figure 3a) . The specificity of the pan-serotype-specific lyophilized assay was also 100% (n = 6), in that no crossreactivity was observed with the other vesicular disease viruses tested (Appendix S1). FMDV RNA was detected in serum from 1-4 days post-challenge, mouth swabs from 2 days onwards post-challenge and all epithelium and OP samples collected post-mortem using the lyophilized pan-serotype-specific reagents (Figure 4 ).
| Initial laboratory analysis of the lyophilized East Africa-specific typing rRT-PCR reagents
For the East African clinical samples tested in the laboratory (n = 36), the serotype-specific typing assay detected 7/8 serotype A, 9/10 serotype O, 7/7 serotype SAT 1 and 10/11 serotype SAT 2 (Appendix S1 and Figure 3b ). Elution from antigen-detection lateral-flow devices (Ag-LFD) was tested for epithelial suspensions only: AE represent Ag-LFD results. Black squares represent dilutions where both replicates were positive for FMDV; grey squares represent dilutions where one replicate was positive; white squares represent reactions where both replicates were negative for FMDV. For the reference rRT-PCR, the use of simple sample preparation methods for epithelium resulted in assay inhibition in known positive samples (bar the use of Ag-LFD) epithelial, 1/1 swab and 3/3 sera samples collected from cattle displaying 1-to 3-day-old lesions. FMDV RNA was identified in 13/14 epithelial, 15/19 swab, 3/4 OP fluid and 3/29 sera samples collected from cattle displaying 4-to 7-day-old lesions. Of the 27 cattle that displayed lesions older than 1 week (8+ days post-initial lesion presentation), FMDV RNA was identified in 3/12 OP fluid samples, whilst all sera (n = 25) and swab (n = 10) samples were negative.
FMDV was not detected in any OP fluid (n = 8), mouth swab (n = 2) or sera (n = 12) sample collected from the 12 clinically negative cattle ( Figure 6 ) (Appendix S2).
Samples considered positive by the lyophilized pan-serotype-specific assay (n = 46), in addition to a selection of samples from cattle considered clinically negative (n = 7), were then subsequently characterized using the East Africa-specific typing assay which has been developed to detect all known FMDV strains relevant to this region . Of these, 24 were identified as F I G U R E 6 In situ real-time reverse transcription PCR (rRT-PCR) results for 144 East African samples using lyophilized rRT-PCR reagents and the T-COR TM 8. Samples were collected from cattle displaying clinical signs of foot-and-mouth disease and cattle with no clinical signs (NCS). Each point represents an average for a single sample (tested in duplicate) on the pan-serotype-specific rRT-PCR (samples that share the same C T will only appear as a single point with individual C T values presented within supplementary data); crossed points indicate that out of the duplicates, one was positive and the other negative. Positive samples were then tested using the typing assay; the colour of the points represents the serotype detected: blue (serotype A), red (serotype O) and white (serotype not detected). FMDV outbreak (Ryan et al., 2008) . However, Ag-LFDs have only been validated for use with epithelial suspension and vesicular fluid, and limited analytical sensitivity restricts their usefulness to the acute stage of infection (Ferris et al., 2009 (Ferris et al., , 2010 . As a consequence, attempts to transfer highly sensitive rRT-PCR assays onto portable detection platforms have been investigated (Hearps et al., 2002; Howson et al., 2015; Madi et al., 2012; Monwina et al., 2007; Paixão et al., 2008) (Sumption et al., 2012) . The future success and implementation of such technologies depends upon several factors, including dissemination of information and adoption of these methodologies into current diagnostic strategies.
The provision of reagents in a lyophilized kit format simplifies reagent storage by negating the requirement for a cold chain, whilst minimizing the requirement for skilled personnel and multiple pipetting stages by streamlining assay set up (assays only require addition of a resuspension buffer and sample). The lyophilized pan-serotypespecific reagents, in combination with the T-COR TM 8, maintained comparable diagnostic performance to the reference rRT-PCR when evaluated with extracted RNA. A one to two log 10 reduction in analytical sensitivity for the lyophilized pan-serotype-specific reagents was evident when no extraction method was used; however, perfor- (Shaw et al., 2007) . Although the provision of simple FMDV-positive/negative results is sufficient for the confirmation of FMD during outbreaks, the value of this information is limited in countries where FMD is endemic. In these situations, it is beneficial to characterize circulating FMDV outbreaks in order to make tailored control programmes a realistic possibility (Namatovu et al., 2013) . In support of this, this study also evaluated a lyophilized version of a published FMDV-typing assay specific to East Africa . The typing assay was able to characterize FMDV present in four different sample types collected from seven small holdings (three in Kenya, three in Tanzania and one in Ethiopia) where cattle were presenting two to sevenday-old FMD lesions. Samples which were unable to be typed | 229
(n = 22) were all considered as weak positives by the lyophilized pan-serotype-specific rRT-PCR (C T > 29) and therefore at the threshold at which characterization information can be routinely obtained by sequencing. The typing assay performance in field settings is therefore consistent with the ability to obtain characterization data within laboratory settings. Two serotypes were detected during the period of testing (O and A), leading to the first reported characterization of FMDV at the pen-side using molecular methods.
In conclusion, this publication describes the laboratory and field evaluation of lyophilized FMDV-specific rRT-PCR assays in combination with a portable thermocycler. The simplicity of the T-COR TM 8
to operate, combined with robust lyophilized reagents, high sensitivity and compatibility with simple sample preparation methods, demonstrates an important transition for FMDV-specific rRT-PCR assays into formats suitable for use on or close to the point-of-care. 
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